Immune checkpoint inhibitors - the revolutionary cancer immunotherapy comes with a cardiotoxic price

被引:6
作者
Achim, Alexandru [1 ,2 ,5 ]
Liblik, Kiera [3 ]
Gevaert, Sofie [4 ]
机构
[1] Kantonsspital Baselland, Med Univ Klin, Klin Kardiol, Liestal, Switzerland
[2] Univ Med & Pharm Iuliu Hatieganu, Niculae Stancioiu Heart Inst, Cluj Napoca, Romania
[3] Queens Univ, Dept Med, Kingston, ON, Canada
[4] Ghent Univ Hosp, Dept Cardiol, Ghent, Belgium
[5] Rheinstr 26, CH-4410 Liestal, Switzerland
关键词
Immune checkpoint inhibitors; ICI; Myocarditis; Cardiotoxicity; Adverse events; CARDIOVASCULAR TOXICITIES; CARDIAC EVENTS; MANIFESTATIONS; MYOCARDITIS; MANAGEMENT; OUTCOMES;
D O I
10.1016/j.tcm.2022.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of immune checkpoint inhibitors (ICIs) has provided a novel and revolutionary treatment option for previously incurable cancers. However, this major advancement is accompanied by a spectrum of cardiotoxic adverse events that are uncommon but potentially fatal. The oncologic indications of ICIs are becoming increasingly complex, requiring robust clinical monitoring to assess for cardiovascular complications. This is reflected in the recent introduction of the first cardio-oncology guidelines, a sign of the cardiovascular community's recognition that seeks to match this dynamic. The aim of this review is to summarize the cardiac side effects of ICI, with an emphasis on prevalence, diagnosis, and treatment options. (c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 52 条
[1]   FAME 3 fails to defame coronary artery bypass grafting: what went wrong in the percutaneous coronary intervention arm? [J].
Achim, Alexandru ;
Leibundgut, Gregor .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (01)
[2]   Reporting of immune checkpoint inhibitor-associated myocarditis [J].
Al-Kindi, Sadeer G. ;
Oliveira, Guilherme H. .
LANCET, 2018, 392 (10145) :382-383
[3]   Immune Checkpoint Inhibitor-Associated Pericarditis [J].
Altan, Mehmet ;
Toki, Maria I. ;
Gettinger, Scott N. ;
Carvajal-Hausdorf, Daniel E. ;
Zugazagoitia, Jon ;
Sinard, John H. ;
Herbst, Roy S. ;
Rimm, David L. .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) :1102-1108
[4]   Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Yokoi, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
de Castro Carpeno, J. ;
Wadsworth, C. ;
Melillo, G. ;
Jiang, H. ;
Huang, Y. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) :1919-1929
[5]   Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis [J].
Awadalla, Magid ;
Mahmood, Syed S. ;
Groarke, John D. ;
Hassan, Malek Z. O. ;
Nohria, Anju ;
Rokicki, Adam ;
Murphy, Sean P. ;
Mercaldo, Nathaniel D. ;
Zhang, Lili ;
Zlotoff, Daniel A. ;
Reynolds, Kerry L. ;
Alvi, Raza M. ;
Banerji, Dahlia ;
Liu, Shiying ;
Heinzerling, Lucie M. ;
Jones-O'Connor, Maeve ;
Bakar, Rula B. ;
Cohen, Justine V. ;
Kirchberger, Michael C. ;
Sullivan, Ryan J. ;
Gupta, Dipti ;
Mulligan, Connor P. ;
Shah, Sachin P. ;
Ganatra, Sarju ;
Rizvi, Muhammad A. ;
Sahni, Gagan ;
Tocchetti, Carlo G. ;
Lawrence, Donald P. ;
Mahmoudi, Michael ;
Devereux, Richard B. ;
Forrestal, Brian J. ;
Mandawat, Anant ;
Lyon, Alexander R. ;
Chen, Carol L. ;
Barac, Ana ;
Hung, Judy ;
Thavendiranathan, Paaladinesh ;
Picard, Michael H. ;
Thuny, Franck ;
Ederhy, Stephane ;
Fradley, Michael G. ;
Neilan, Tomas G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (05) :467-478
[6]   Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors [J].
Baik, Alan H. ;
Tsai, Katy K. ;
Oh, David Y. ;
Aras, Mandar A. .
CLINICAL SCIENCE, 2021, 135 (05) :703-724
[7]   Cardiovascular Toxicities of Immune Checkpoint Inhibitors JACC Review Topic of the Week [J].
Ball, Somedeb ;
Ghosh, Raktim K. ;
Wongsaengsak, Sariya ;
Bandyopadhyay, Dhrubajyoti ;
Ghosh, Gopal Chandra ;
Aronow, Wilbert S. ;
Fonarow, Gregg C. ;
Lenihan, Daniel J. ;
Bhatt, Deepak L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) :1716-1727
[8]   Myocarditis in the Setting of Cancer Therapeutics Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology [J].
Bonaca, Marc P. ;
Olenchock, Benjamin A. ;
Salem, Joe-Elie ;
Wiviott, Stephen D. ;
Ederhy, Stephane ;
Cohen, Ariel ;
Stewart, Garrick C. ;
Choueiri, Toni K. ;
Di Carli, Marcelo ;
Allenbach, Yves ;
Kumbhani, Dharam J. ;
Heinzerling, Lucie ;
Amiri-Kordestani, Laleh ;
Lyon, Alexander R. ;
Thavendiranathan, Paaladinesh ;
Padera, Robert ;
Lichtman, Andrew ;
Liu, Peter P. ;
Johnson, Douglas B. ;
Moslehi, Javid .
CIRCULATION, 2019, 140 (01) :80-91
[9]   Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline [J].
Brahmer, Julie R. ;
Lacchetti, Christina ;
Schneider, Bryan J. ;
Atkins, Michael B. ;
Brassil, Kelly J. ;
Caterino, Jeffrey M. ;
Chau, Ian ;
Ernstoff, Marc S. ;
Gardner, Jennifer M. ;
Ginex, Pamela ;
Hallmeyer, Sigrun ;
Chakrabarty, Jennifer Holter ;
Leighl, Natasha B. ;
Mammen, Jennifer S. ;
McDermott, David F. ;
Naing, Aung ;
Nastoupil, Loretta J. ;
Phillips, Tanyanika ;
Porter, Laura D. ;
Puzanov, Igor ;
Reichner, Cristina A. ;
Santomasso, Bianca D. ;
Seigel, Carole ;
Spira, Alexander ;
Suarez-Almazor, Maria E. ;
Wang, Yinghong ;
Weber, Jeffrey S. ;
Wolchok, Jedd D. ;
Thompson, John A. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) :1714-+
[10]   Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immunooncology [J].
Chen, Dong-Yi ;
Huang, Wen-Kuan ;
Wu, Victor Chien-Chia ;
Chang, Wen-Cheng ;
Chen, Jen-Shi ;
Chuang, Cheng-Keng ;
Chu, Pao-Hsien .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (10) :1461-1475